Related Experiment Video
Updated: Feb 8, 2026

Lexical Decision Task for Studying Written Word Recognition in Adults with and without Dementia or Mild Cognitive Impairment
Published on: June 25, 2019
Amyloid deposition and CBF patterns predict conversion of mild cognitive impairment to dementia
Takayuki Kikukawa1, Takato Abe2, Suzuka Ataka1
1Department of Neurology, Osaka City University Graduate School of Medicine, 1-4-3, Asahimachi ,Abeno-ku, Osaka, 545-8585, Japan.
Abstract:
Mild cognitive impairment (MCI) can include the transition from a normal state to dementia. To explore biomarkers for the development of dementia, we performed an 18-month follow-up study in 28 patients with amnestic MCI. Amyloid deposition was examined using PiB PET, and cerebral blood flow (CBF) was examined using SPECT. Cognitive function was periodically assessed. The rate of conversion to dementia was higher in the PiB-positive/equivocal group (74%) than in the PiB-negative group (33%) (p = 0.041). Perfusion SPECT was performed in 16 patients. MCI patients with an AD-characteristic pattern of reduced CBF had a higher PiB-positive/equivocal rate (82%) than those with a non-AD pattern (20%) (p = 0.018), and patients with an AD pattern had a higher conversion rate (82%) than those with a non-AD pattern (40%) (p = 0.094). Clinically, all PiB-positive converters were diagnosed as having Alzheimer's disease (AD), whereas PiB-negative converters were thought to have some form of dementia other than AD. Amyloid PET is useful for predicting conversion to AD in MCI patients. A pattern analysis of perfusion SPECT findings might also be helpful for predicting conversion to AD, but with a lower specificity.
Insights
Amyloid PET scans can predict Alzheimer's disease (AD) progression in mild cognitive impairment (MCI) patients. Reduced cerebral blood flow patterns also indicate higher dementia conversion risk.
Area of Science:
- Neuroimaging
- Neurology
- Biomarkers
Background:
- Mild cognitive impairment (MCI) represents a transitional stage between normal cognition and dementia.
- Identifying reliable biomarkers for dementia development is crucial for early intervention.
Purpose of the Study:
- To investigate amyloid deposition using PiB PET and cerebral blood flow (CBF) using SPECT as biomarkers for dementia development in amnestic MCI patients.
- To assess the predictive value of these biomarkers for conversion to Alzheimer's disease (AD).
Main Methods:
- An 18-month follow-up study involving 28 patients with amnestic MCI.
- Amyloid deposition was measured using Pittsburgh Compound B (PiB) Positron Emission Tomography (PET).
- Cerebral blood flow (CBF) was assessed using Single-Photon Emission Computed Tomography (SPECT) in a subset of patients.
Main Results:
- Patients with positive or equivocal PiB PET results showed a significantly higher conversion rate to dementia (74%) compared to PiB-negative patients (33%).
- MCI patients exhibiting an AD-characteristic pattern of reduced CBF had a higher rate of positive/equivocal PiB scans (82%) and a higher conversion rate to dementia (82%).
- All PiB-positive converters were diagnosed with AD, while PiB-negative converters were diagnosed with other forms of dementia.
Conclusions:
- Amyloid PET imaging is a valuable tool for predicting conversion to AD in individuals with MCI.
- Perfusion SPECT patterns suggestive of AD may also aid in predicting conversion, although with lower specificity than amyloid PET.
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Cognitive Dissonance
Gene Conversion
Gene Conversion

